Logiscreen

Monte Rosa Therapeutics Inc

$14.07
Market Cap 1.19B
ROE -43.3%
Gross Margin 100.0%
Debt/Equity 0.1
Current Ratio 10.6
Revenue QoQ -61.3%
EPS QoQ 1.9%
F-Score 3

About

Monte Rosa Therapeutics Inc

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-14.18
vs median 36.93
P/B
3.53
vs median 2.32
ROE
-0.41
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

STOKGENBTSHAURGNRXRXPGEN
Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics